| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/27/2008 | CN101132768A Nanoparticulate tacrolimus formulations |
| 02/27/2008 | CN101132693A Compositions and methods for the management of hyperproliferative dermatological conditions |
| 02/27/2008 | CN101130801A Preparation of active antihypertensive peptide product |
| 02/27/2008 | CN101130775A Novel signal conotoxin sequence and preparing method and application thereof |
| 02/27/2008 | CN101130724A Health care beer having auxiliary inhibit function for tumour and method of producing the same |
| 02/27/2008 | CN101130571A Human ring protein, encoding gene and application of the same |
| 02/27/2008 | CN101130514A Intermediate for the preparation of epimino |
| 02/27/2008 | CN101130090A Application of BRSK2 in producing antidiabetic medicine |
| 02/27/2008 | CN101130081A Use of PNAS-4 gene in preparing antineoplastic and antineoplastic auxiliary medicament |
| 02/27/2008 | CN101130078A Intrathecal administration of rituximab for treatment of central nervous system lymphomas |
| 02/27/2008 | CN101130077A Remedy for spinal injury containing interleukin-6 antagonist |
| 02/27/2008 | CN101130069A Use of calmodulin kinase ii inhibitors to treat myocardial dysfunction in structural heart disease |
| 02/27/2008 | CN101130068A SOD slimming wine and its production process |
| 02/27/2008 | CN101130067A Preparation for replenishing collagen and method of preparing the same |
| 02/27/2008 | CN101130066A Segmented intestine targeted preparation of animal skin glue collagen polypeptide and method of preparing the same |
| 02/27/2008 | CN101130065A Soft capsule of pearl calcium and method of preparing the same |
| 02/27/2008 | CN101130064A Freeze dried injection for treating type 2 diabetes and method of preparing the same |
| 02/27/2008 | CN101130063A Segmented intestine targeted preparation of orgotein polypeptide and method of preparing the same |
| 02/27/2008 | CN101130062A Segmented intestine targeted drug feeding preparation of brain protein polypeptide and method of preparing the same |
| 02/27/2008 | CN101130061A Segmented intestine targeted drug feeding preparation of myocardium protein polypeptide and method of producing the same |
| 02/27/2008 | CN101130060A Medical composition containing dalbavancin |
| 02/27/2008 | CN101130059A Self-micro emulsifying soft capsule of cyclosporine A and method of producing the same |
| 02/27/2008 | CN101130058A Emulsion of cyclosporin A for eyes and method of producing the same |
| 02/27/2008 | CN101130057A Long-acting implantation agent of pentapeptide for thymus gland and method of producing the same |
| 02/27/2008 | CN101129344A Methods, assays and compositions for treating retinol-related diseases |
| 02/27/2008 | CN101129333A Method of preparing nano slow release agent for simplifying animal FSH superovulation |
| 02/27/2008 | CN101129327A Micro-projection array having a beneficial agent containing coating |
| 02/27/2008 | CN100371442C Ligand/receptor specificity exchangers that redirect antibodies to receptors on pathogen |
| 02/27/2008 | CN100371439C Preparation method of recombinant can diad urate oxidase |
| 02/27/2008 | CN100371349C Recombination immune therapeutic protein and its expression method and application |
| 02/27/2008 | CN100371348C Treatment of micro-organism infection |
| 02/27/2008 | CN100371347C Active material of polypeptide proteins in bloody clam, preparation method and usage |
| 02/27/2008 | CN100371346C Artificial synthesized insulin-simulated peptide and its application |
| 02/27/2008 | CN100371345C Perindopril |
| 02/27/2008 | CN100371019C Uro-genital condition treatment system |
| 02/27/2008 | CN100371018C Calcitonin composition |
| 02/27/2008 | CN100371017C Use of biological keratin for pharmaceutical preparation |
| 02/27/2008 | CN100370967C Implantable gel compositions and preparing method of thereof |
| 02/26/2008 | USRE40119 Adjunctive therapy |
| 02/26/2008 | US7335764 12 to 30 nucleobases in length targeted to a nucleic acid molecule encoding acyl CoA cholesterol acyltransferase-2 that hybridizes with and inhibits the expression; treating atherosclerosis, cardiovascular disorders or metabolism disorders |
| 02/26/2008 | US7335759 Recombinant immunogens for the generation of antivenoms to the venom of scorpions of the genus Centruroides |
| 02/26/2008 | US7335758 Catalytic domain of ADAM33 and methods of use thereof |
| 02/26/2008 | US7335756 Isolated nucleic acid comprising polynucleotide of given sequence; diagnostic kits; use in treatment of cancer |
| 02/26/2008 | US7335754 Ehrlichia canis genes and vaccines |
| 02/26/2008 | US7335750 Hybrid compositions for intracellular targeting |
| 02/26/2008 | US7335749 Identifying modulators of antitumor activity; diagnosis, prevention and treatment of cancer |
| 02/26/2008 | US7335746 PRO polypeptides; fusion proteins; immunoglobulins; cytokines; for stimulating release of tumor necrosis factor from blood; for modulating uptake of glucose by adipocyte cells; for release of proteoglycans from cartilage |
| 02/26/2008 | US7335745 Vectors with DNA encoding pro polypeptides |
| 02/26/2008 | US7335740 Monoclonal antibody for use in diagnosis, treatment and prevention of cell proliferative, inflammatory, nervous system and immunological disorders |
| 02/26/2008 | US7335739 Methods for the purification and aqueous fiber spinning of spider silks and other structural proteins |
| 02/26/2008 | US7335737 Oocyte-specific gene; protein encoding antibody; controlling cell differentiation, cell proliferation; antitumor agents; contraceptives |
| 02/26/2008 | US7335735 Intracellular estradiol binding protein (IEBP) for use as tool in identifying modulator for treatment and prevention of bone and cell proliferative disorders |
| 02/26/2008 | US7335734 Protein polymer having unfold activity on higher-order structure of protein |
| 02/26/2008 | US7335733 Tissue cement proteins from Rhipicephalus appendiculatus |
| 02/26/2008 | US7335732 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders |
| 02/26/2008 | US7335731 PRO4332 polypeptides |
| 02/26/2008 | US7335730 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders |
| 02/26/2008 | US7335729 PRO4320 polypeptide |
| 02/26/2008 | US7335727 fusion inhibitor; high stability and high valence; higher efficacy, and lower administration dosage, and thereby lower toxicity. |
| 02/26/2008 | US7335726 antibiotic daptomycin stereoisomeric compounds; expected to be useful to treat not only "natural" pathogens, but also intermediate drug resistant and drug resistant pathogens |
| 02/26/2008 | US7335725 Lipopeptides as antibacterial agents |
| 02/26/2008 | US7335723 Melanin-concentrating hormone antagonists |
| 02/26/2008 | US7335722 For use in pharmaceuticals, food additivs |
| 02/26/2008 | US7335649 3-{N'-[1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-2-hydroxy-3'-(tetrazol-5-yl)biphenyl for treatment of thrombocytopenia; colony stimulating factors |
| 02/26/2008 | US7335647 Drugs for liver diseases |
| 02/26/2008 | US7335646 Compositions and methods for regulated protein expression in gut |
| 02/26/2008 | US7335645 For prophylaxis or treatment of skin or mucosa, autoimmune diseases and inflammation |
| 02/26/2008 | US7335644 Angiotensin Converting Enzyme Inhibitors (ACEI); used to regulate blood pressure; enhanced bioavailability and fewer side effects |
| 02/26/2008 | US7335643 Compositions of active Wnt protein |
| 02/26/2008 | US7335642 Administering a peptide having the amino acid sequence Tyr-D-Leu-Phe-Ala-Asp-Val-Ala-Ser-Thr-Ile-Gly-Asp-Phe-Phe-His-Ser-Ile-NH2 to treat viral infections; inflammation, reaction to toxin of ethanol, lead, carbon tetrachloride or acetaminophen, or from trauma resulting in ischemia; reperfusion injuries |
| 02/26/2008 | US7335641 Method for stimulating hair follicle cell proliferation |
| 02/26/2008 | US7335640 Using hypocretin receptor agonist; sleep disorders |
| 02/26/2008 | US7335639 IGF-1 composition and its use |
| 02/26/2008 | US7335638 Prevention and treatment of mycoplasma-associated diseases |
| 02/26/2008 | US7335637 Biglycan and related therapeutics and methods of use |
| 02/26/2008 | US7335636 SPRR1A and axonal regeneration |
| 02/26/2008 | US7335635 14-3-3 binding molecules as sensitizers for anticancer therapies |
| 02/26/2008 | US7335634 Von Willebrand Factor (VWF); prevents a bleeding diathesis and reduces pre-, peri- and postoperative blood loss in acquired Von Willebrand syndromes such as in cardiovascular diseases requiring surgical procedures |
| 02/26/2008 | US7335633 Detecting recurrent vulvovaginal candidiasis or vulvar vestibulitis syndrome and method for treating same |
| 02/26/2008 | US7335632 Selectively inhibit memapsin 2 beta -secretase activity relative to memapsin 1 beta -secretase activity; Alzheimer's disease |
| 02/26/2008 | US7335516 Methods to improve immunogenicity of antigens and specificity of antibodies |
| 02/26/2008 | US7335504 Engineered enzymes and uses thereof |
| 02/26/2008 | US7335499 tRNA synthetase |
| 02/26/2008 | US7335495 Washing leaves of Porteresia coarctata with sterile sea water, growing fungus on washed leaves; identifying, purification, transferring purified colony; growing culture medial, removing biomass; freeze drying, solvent extraction |
| 02/26/2008 | US7335492 Process for partitioning of proteins |
| 02/26/2008 | US7335490 administering genetic engineered erythropoietin produced in host cells expressing EIA protein of an adenovirus, and optionally statins and angiotensin converting enzyme inhibitors; cardiovascular disorders |
| 02/26/2008 | US7335489 Polynucleotides encoding a protein kinase C inhibitor protein and methods of using these polynucleotides |
| 02/26/2008 | US7335484 Drug screening via exposing transfected cells to drugs and analyzing expression/retinoid oxidation; oxidases, hydroxylases |
| 02/26/2008 | US7335482 Method using neutral amino acid transporter expressing cell |
| 02/26/2008 | US7335475 nucleotide sequences coding tumor suppressor (PR/SET) polypeptides for diagnosis, prognosis and treatment of cell proliferative disorders; anticarcinogenic agents; tumor suppressor genes |
| 02/26/2008 | US7335469 Methods for diagnosing Noonan syndrome |
| 02/26/2008 | US7335468 Isolated protein complexes; screening analyzing; human t-cell leukemia virus |
| 02/26/2008 | US7335383 Generation of nitric oxide in vivo from nitrite, nitrate or nitrosothiols endogenous in blood |
| 02/26/2008 | US7335377 apparatus that generates hydrophilic micro-channels, and a patch comprising the bioactive agent; for delivery of hydrophilic agents, particularly proteins such as insulin or human growth hormone |
| 02/26/2008 | US7335370 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 02/26/2008 | US7335369 Fusion proteins of mycobacterium tuberculosis antigens and their uses |
| 02/26/2008 | US7335368 BVH-A2 and BVH-A3 antigens of group B Streptococcus |
| 02/26/2008 | US7335367 Reducing secretions from the meibomian glands; vision defects |
| 02/26/2008 | US7335365 HIV-encoded chemoattractant |
| 02/26/2008 | US7335362 Methods of treating pre-eclampsia or eclampsia |